Literature DB >> 2403441

Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly.

H Vennema1, L Heijnen, A Zijderveld, M C Horzinek, W J Spaan.   

Abstract

Coronavirus spike protein genes were expressed in vitro by using the recombinant vaccinia virus expression system. Recombinant spike proteins were expressed at the cell surface and induced cell fusion in a host-cell-dependent fashion. The intracellular transport of recombinant spike proteins was studied. The half time of acquisition of resistance to endo-beta-N-acetylglucosaminidase H was approximately 3 h for the recombinant feline infectious peritonitis virus S protein. The S protein in feline infectious peritonitis virus-infected cells was found to have a half time of acquisition of resistance to endo-beta-N-acetylglucosaminidase H of approximately 1 h. This difference can be explained by the fact that coronavirus budding takes place at intracellular membranes and that the oligosaccharides of the spike protein are modified after budding. Apparently, spike protein incorporated into budded virions is transported faster through the Golgi apparatus than is spike protein alone. These findings provide new insights into the mechanism of coronavirus budding and are discussed in relation to current models of intracellular transport and sorting of proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403441      PMCID: PMC249107     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Localization of two cellular forms of the vesicular stomatitis viral glycoprotein.

Authors:  D M Knipe; H F Lodish; D Baltimore
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

2.  Immunologic phenomena in the effusive form of feline infectious peritonitis.

Authors:  N C Petersen; J F Boyle
Journal:  Am J Vet Res       Date:  1980-06       Impact factor: 1.156

3.  Expression from cloned cDNA of cell-surface secreted forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cells.

Authors:  J K Rose; J E Bergmann
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

4.  Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy.

Authors:  G D Johnson; R S Davidson; K C McNamee; G Russell; D Goodwin; E J Holborow
Journal:  J Immunol Methods       Date:  1982-12-17       Impact factor: 2.303

5.  Coronavirus proteins: structure and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins.

Authors:  D F Stern; B M Sefton
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

6.  Morphogenesis of a virus in cats with experimental feline infectious peritonitis.

Authors:  J M Ward
Journal:  Virology       Date:  1970-05       Impact factor: 3.616

7.  Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin.

Authors:  P J Rottier; M C Horzinek; B A van der Zeijst
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

8.  Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice.

Authors:  R J De Groot; R W Van Leen; M J Dalderup; H Vennema; M C Horzinek; W J Spaan
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

9.  Coronavirus glycoprotein E1, a new type of viral glycoprotein.

Authors:  H Niemann; H D Klenk
Journal:  J Mol Biol       Date:  1981-12-25       Impact factor: 5.469

10.  Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein.

Authors:  K V Holmes; E W Doller; L S Sturman
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

View more
  84 in total

1.  Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion.

Authors:  Z Luo; A M Matthews; S R Weiss
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Assembly of the coronavirus envelope: homotypic interactions between the M proteins.

Authors:  C A de Haan; H Vennema; P J Rottier
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  A novel glycoprotein of feline infectious peritonitis coronavirus contains a KDEL-like endoplasmic reticulum retention signal.

Authors:  H Vennema; L Heijnen; P J Rottier; M C Horzinek; W J Spaan
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations.

Authors:  Gijs A Versteeg; Paula S van de Nes; Peter J Bredenbeek; Willy J M Spaan
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

Review 5.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

6.  Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein.

Authors:  T M Gallagher; C Escarmis; M J Buchmeier
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation.

Authors:  C A M de Haan; B J Haijema; P Schellen; P Wichgers Schreur; E te Lintelo; H Vennema; P J M Rottier
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

8.  Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapter.

Authors:  M H Verheije; T Würdinger; V W van Beusechem; C A M de Haan; W R Gerritsen; P J M Rottier
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells.

Authors:  D W Yoo; M D Parker; L A Babiuk
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

10.  Analysis of murine coronavirus surface glycoprotein functions by using monoclonal antibodies.

Authors:  E Routledge; R Stauber; M Pfleiderer; S G Siddell
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.